Print this page
Monday, 07 August 2017 09:21

Cerium Oxide Nanoparticles Improve Outcome After In Vitro and In Vivo Mild Traumatic Brain Injury

Written by

 

Brain injury continues to present a significant treatment challenge. Not only is initial, life-saving management of these patients complicated, but progress with improving long-term neurological prognosis is slow. In such a climate, it is necessary to investigate the use of new therapies. In this article, the authors discuss the use of cerium oxide nanoparticles in models of neurological injury. The implication of free-radicals in exacerbating brain injury is demonstrated, and also the use of antioxidants to address this.

 

Read the article

Last modified on Wednesday, 16 August 2017 08:17
Dom Mahoney, MS

Latest from Dom Mahoney, MS